289 related articles for article (PubMed ID: 32653467)
1. Rational use of mucoactive medications to treat pediatric airway disease.
Linssen RSN; Ma J; Bem RA; Rubin BK
Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
[TBL] [Abstract][Full Text] [Related]
2. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
3. Dornase alfa for cystic fibrosis.
Yang C; Chilvers M; Montgomery M; Nolan SJ
Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
[TBL] [Abstract][Full Text] [Related]
4. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A
Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
[TBL] [Abstract][Full Text] [Related]
6. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
[TBL] [Abstract][Full Text] [Related]
7. The use of pulmonary clearance medications in the acutely ill patient.
Papacostas MF; Luckett P; Hupp S
Expert Rev Respir Med; 2017 Oct; 11(10):815-826. PubMed ID: 28780895
[TBL] [Abstract][Full Text] [Related]
8. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
Bilton D; Stanford G
Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
[TBL] [Abstract][Full Text] [Related]
9. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
10. Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis.
Amirav I; Cohen-Cymberknoh M; Shoseyov D; Kerem E
Paediatr Respir Rev; 2009 Jun; 10(2):58-62. PubMed ID: 19410203
[TBL] [Abstract][Full Text] [Related]
11. Other medications for aerosol delivery.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S76-9. PubMed ID: 16798603
[TBL] [Abstract][Full Text] [Related]
12. Dornase in non-CF.
Ratjen F
Pediatr Pulmonol Suppl; 2004; 26():154-5. PubMed ID: 15029636
[No Abstract] [Full Text] [Related]
13. Role of mucolytics in wet cough.
Dhar R
J Assoc Physicians India; 2013 May; 61(5 Suppl):23-7. PubMed ID: 24490447
[No Abstract] [Full Text] [Related]
14. Dornase alfa for cystic fibrosis.
Jones AP; Wallis C
Cochrane Database Syst Rev; 2010 Mar; (3):CD001127. PubMed ID: 20238314
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized agents for airway clearance in cystic fibrosis.
Southern KW; Clancy JP; Ranganathan S
Pediatr Pulmonol; 2019 Jun; 54(6):858-864. PubMed ID: 30884217
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
Boogaard R; de Jongste JC; Merkus PJ
Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
[TBL] [Abstract][Full Text] [Related]
17. The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
Icard BL; Rubio E
Expert Rev Respir Med; 2017 Oct; 11(10):807-814. PubMed ID: 28737047
[TBL] [Abstract][Full Text] [Related]
18. Early treatment with dornase alfa in cystic fibrosis: what are the issues?
Bush A
Pediatr Pulmonol; 1998 Feb; 25(2):79-82. PubMed ID: 9516089
[No Abstract] [Full Text] [Related]
19. The overuse or underuse of dornase alfa.
Shah PL; Hodson ME
Curr Opin Pulm Med; 1997 Nov; 3(6):410-3. PubMed ID: 9391759
[TBL] [Abstract][Full Text] [Related]
20. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
